# Q Therapeutics, Inc.

Q Therapeutics, Inc. is a company headquartered in Salt Lake City, UT, United States.

## Company overview

- **Legal name:** Q Therapeutics, Inc.
- **Former names in filing history:** Q Holdings, Inc. (2011-11-14 to 2012-12-18); Grace 2, Inc. (2006-06-19 to 2011-12-02)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Salt Lake City, UT, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001366541

## About

Q Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001366541, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2015-03-31, it reported annual revenue of USD 680,264; net income of USD -3,350,701; total assets of USD 748,311 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $680,264 (USD 680,264)
- **Net income:** -$3.4M (USD -3,350,701)
- **Total assets:** $748,311 (USD 748,311)
- **Cash and equivalents:** $707,011 (USD 707,011)
- **Operating cash flow:** -$1.5M (USD -1,458,653)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $26,175 (USD 26,175)
- **Net income:** -$3.4M (USD -3,389,092)
- **Total assets:** $257,042 (USD 257,042)
- **Cash and equivalents:** $142,532 (USD 142,532)
- **Operating cash flow:** -$877,873 (USD -877,873)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $485,031 (USD 485,031)
- **Net income:** -$3.1M (USD -3,057,840)
- **Total assets:** $1.3M (USD 1,305,932)
- **Cash and equivalents:** $794,207 (USD 794,207)
- **Operating cash flow:** -$2.1M (USD -2,121,749)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $174,573 (USD 174,573)
- **Net income:** -$2.6M (USD -2,599,338)
- **Total assets:** $2.8M (USD 2,834,751)
- **Operating cash flow:** -$1.7M (USD -1,665,370)

## Recent SEC filings

- Form 8-K — filed 2015-12-17 — period 2015-12-11 — 8-K
- Form 8-K — filed 2015-11-19 — period 2015-11-18 — FORM 8-K
- Form 10-Q — filed 2015-11-13 — period 2015-09-30 — 10-Q
- Form 8-K — filed 2015-09-14 — period 2015-09-09 — FORM 8-K
- Form 10-Q — filed 2015-08-14 — period 2015-06-30 — FORM 10-Q
- Form 8-K — filed 2015-06-04 — period 2015-06-04 — 8-K
- Form 10-Q — filed 2015-05-11 — period 2015-03-31 — FORM 10-Q
- Form 10-K — filed 2015-03-31 — period 2014-12-31 — 10-K
- Form 8-K — filed 2015-03-31 — period 2015-03-30 — FORM 8-K
- Form 8-K — filed 2014-12-19 — period 2014-12-15 — 8-K
- Form 10-Q — filed 2014-11-07 — period 2014-09-30 — 10-Q
- Form 8-K — filed 2014-09-23 — period 2014-09-16 — FORM 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/q-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology